Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 3, 2003, Pages 322-329

  Shinde, Urmila A ^a   Goyal, R K ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Chromium picolinate; Diabetes mellitus; Histopathology; Renal function, hepatic function; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CHROMIUM PICOLINATE; CREATININE; DRINKING WATER; GLUCOSE; INSULIN; LIVER ENZYME; STREPTOZOCIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE; DISEASE COURSE; DRUG EFFECT; DRUG EXPOSURE; ENZYME BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOLOGY; HISTOPATHOLOGY; HYPERTROPHY; INCIDENCE; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; KIDNEY; KIDNEY FUNCTION; LIVER; LIVER FUNCTION; LIVER TOXICITY; LONG TERM CARE; MALE; NEPHROTOXICITY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; UREA BLOOD LEVEL;

ANIMALIA;

EID: 0242606933     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00233.x     Document Type: Article

References (29)

1. DeFronzo R.A., Lilly Lecture 1987: the triumvirate: -cell, muscle, liver: a collusion responsible for NIDDM, Diabetes, 37: 667-687, 1988
2. Bailey C.J., Potential new treatments for type 2 diabetes, TIPS, 21: 259-265, 2000
3. Mertz W., Chromium in human nutrition: a review, J. Nutr., 123: 626-633, 1993
4. Anderson R.A., Chromium, glucose tolerance, diabetes and lipid metabolism, J. Adv. Med., 8: 37-49, 1995
5. Anderson R.A., Recent advances in the clinical and biochemical manifestation of chromium deficiency in human and animal nutrition, J. Trace. Elem. Exp. Med., 11: 241-250, 1998
6. Shinde U.A., Goyal R.K., Insulin sensitizing action of chromium in experimental models of diabetes mellitus, Indian J. Pharmacol., 33: 51, 2001
7. Shinde U.A., Goyal R.K., Mechanism of anti-diabetic action of chromium, Indian J. Pharmacol., 34: 142, 2002
8. Jensen P.K., Christiansen J.S., Steven K., Parving H.H., Renal function in streptozotocin-diabetic rats, Diabetologia, 21: 409-414, 1981
9. Bleasel A.F., Yong C.J., Streptozotocin induced diabetic nephropathy and renal tumors in the rat, Experientia, 38: 129-130, 1982
10. Domingo J.L., Gomez M., Llobet J.M., Corbella J., Keen C.L., Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used, Toxicology, 66: 279-287, 1991
11. Domingo J.L., Gomez M., Llobet J.M., Corbella J., Keen C.L., Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects, Pharmacol. Toxicol., 68: 249-253, 1991
12. Matsuda M., DeFronzo R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, Diabetes Care, 22: 1462-1470, 1999
13. Ross M.H., Reith E.J., Romrell L.J., Histology. A text an atlas (ki sp k), Williams & Wilkins, Baltimore, Maryland, 1989, pp. 1-2
14. Tisher C.C., Anatomy of the kidney. In: Brenner B., Rector F., eds., The Kidney, vol.2, WB Saunders, Philadelphia, 1981, pp. 3-75
15. Cam M.C., Pederson R.A., Brownsey R.W., McNeill J.H., Long-term effectiveness of oral vanadyl sulfate in STZ-diabetic rats, Diabetologia, 36: 218-224, 1993
16. Dai S., Yuen V.G., Orvig C., McNeill J.H., Prevention of diabetes-induced pathology in STZ-diabetic rats by bis(maltolato)oxovanadium (IV), Pharmacol. Commun., 3: 311-321, 1993
17. Brown D.M., Andres G.A., Hostetter T.H., Mauer S.M., Price R., Venkatachalam M.A., Kidney complications, Diabetes, 31: 71-81, 1982
18. Cohen A.J., McGill P.D., Rossetti R.G., Guberski D.L., Like A.A., Glomerulopathy in spontaneously diabetic rats. Impact of glycemic control, Diabetes, 36: 944-951, 1987
19. Lee C.S., Mauer S.M., Brown D.M., Sutherland D.E., Michael A.F., Najarian J.S., Renal transplantation in diabetes mellitus in rats, J. Exp. Med., 139: 793-801, 1974
20. Mauer S.M., Sutherland D.E.R., Steffes M.W., Leonard R.J., Najarian J.S., Michael A.F., Brown D.M., Pancreatic islet transplantation. Effects on the glomerular lesions of experimental diabetes in the rat, Diabetes, 23: 748-753, 1974
21. Fox C.J., Darby S.C., Ireland J.T., Sonkensen P.H., Blood glucose control and glomerular capillary basement membrane thickening in experimental diabetes, Br. Med. J., 2: 605-607, 1977
22. Rasch P., Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment, Diabetologia, 16: 319-324, 1979
23. Rasch R., Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions, Diabetologia, 17: 243-248, 1979
24. Rasch R., Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Albumin excretion, Diabetologia, 18: 413-416, 1980
25. Evan A.P., Mong S.A., The effect of streptozotocin induced diabetes on kidney, Renal Physiol., 7: 78-89, 1984
26. Mertz W., Biological role of chromium, Fed. Proc., 26: 186-193, 1967
27. Cerulli J., Grabe D.W., Gauthier I., Malone M., McGoldrick M.D., Chromium picolinate toxicity, Ann. Pharmacother., 32: 428-431, 1998
28. Wasser W.G., Feldman N.S., D'Agati V.D., Chronic renal failure after ingestion of over-the-counter chromium picolinate, Ann. Intern. Med. 126: 410, 1997
29. Glick M.E., Hoefs J.C., Meshkinpour H., Glucose intolerance and hepatic, biliary tract and pancreatic dysfunction, Dig. Dis. 5: 78-96, 1987